Inventor

NICKISCH KLAUS

DE53 patents

⚠️ This page may combine multiple inventors who share the name “NICKISCH KLAUS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NICKISCH KLAUS

SCHERING AG

Process for production drospirenone and intermediate products of the process

Process for the production of N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes

PROCESSING FOR PRODUCING OF DROSPIRENONE (6β, 7β, 15β, 16β-DIMETHYLENE-3-OXO-17α-PREGN-4-EN-21, 17-CARBOLACTONE, DRSP) AS WELL AS 7α-(3-HYDOXY-1-PROPLY)-6β, 7β; 15β, 16β-DIMETHYLENE-5β-ANDROSTANE-3β, 5,17β-TRIOL(ZK 92836) AND 6β, 7β; 15β, 16β-DIMETHYLENE-5β-HYDROXY

Process for preparing 3β7β-dihydroxy-Δ5 -steroids

Process for preparing 3β,7β-dihydroxy-Δ5 -steroids

Derivatized alkanolamines as cardiovascular agents

Process for the production of b-carbolines

17-Substituted estradienes and estratrienes

1α,7α-dithio-substituted spirolactones, processes for their preparation, and their use as medicines

Novel androstane derivatives, process for their production, and pharmaceutical preparations containing them

Androstane derivatives, process for their production, and pharmaceutical preparations containing them

7α-Alkoxycarbonyl-15β,16β-methylene-4-androstenes, process for the preparation thereof, and use thereof as medicinal agents

Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use and process for their production

N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4(methylsulfonylamino)benzamides

Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%

Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents

Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents

Multiply-tritiated steroidal-20,17-spirolactones and their use as tracer compounds

Process for the production of 1,4,7,10-tetraazacyclododecane and its derivatives

2,2:6,6-diethylen-3-oxo-17alpha-pregn-4-ene-21,17alpha-carbolactones, process for their production &amp; pharmaceutical preparations containing them

7α-Substituted 3-oxo-17α-pregn-4-ene-21,17-carbolactones, process for their production, and pharmaceutical preparations containing same

15,16 -Methylene-17α-pregna-4,6-diene-21-carboxylic acid salts, pharmaceutical preparations containing them and a process for their production

7.alpha.-Acylthio-15,16-methylene-3-oxo-17α-pregna-1,4-diene-21,17-carbolactones, their preparation and use as medicinal agents

Dermatics utilizing 17βmethyl-18 nor steroids and methods for their use

Process for the preparation of 1-methylandrosta-1,4-diene-3,17,dione, and the novel intermediates for this process

1-(4-Substituted phenyl)-1H-imidazoles compounds

Process for the production of ergoline derivatives

Process for the production of arabinonucleosides

Fermentation process for the production of β-carboline derivatives by Myrothecium verrucaria

7α-Acylthio-1α,2α-methylene-3-oxo-17α-pregn-4-ene-21,17-carbolactones, their production and pharmaceutical preparations containing them

Selective phenylation of 5-hydroxy-β-carboline derivatives

5β-Hydroxy-Δ6 -steroids and process for the preparation thereof

Process for the production of indole derivatives

2-iodo-3-keto-Δ4 steroids, process for their production, as well as their further processing

17α-Pregn-4-ene-3-oxo-21-carboxylic acid esters, process for the preparation thereof, and use thereof as medicinal agents

Process for the production of 1-methyl-3-keto-Δ1,4 steroids

Process for the production of 17-oxosteroids via the fermentative oxidation of 17β-hydroxysteroids by Mycobacterium

Process for the production of gramine derivatives

Process for the production of C-substituted diethylenetriamines

EVESTRA INC

Bismethylene-17A carbolactones and related uses

Pro-drug forming compounds

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Pro-drug forming compounds

Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer

Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents

Longer-acting progestin prodrug contraceptives

NICKISCH KLAUS

Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones

Progesterone antagonists

Methods for the preparation of drospirenone

BAYER SCHERING PHARMA AG

Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5%

2,2:6,6-diethylen-3-oxo-17alpha-pregn-4-ene-21,17alpha-carbolactones, process for their production & pharmaceutical preparations containing them